Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early health technology assessment (eHTA) approaches focused on human stem cell-related technologies: a scoping review protocol.

BMJ open·2026
Same author

Scaling-Up Vertical-Wheel Bioreactors Based on Cell Aggregate Exposure to Shear Stress and Energy Dissipation Rate.

Annals of biomedical engineering·2026
Same author

Advancing regenerative medicine with RNA nanotechnology for chronic and end organ diseases.

Communications medicine·2026
Same author

Human pluripotent stem cell-derived atrioventricular node-like pacemaker cells exhibit biological conduction bridge properties.

Cell stem cell·2026
Same author

Bright Ferritin for Non-Invasive MRI Monitoring of the Fate of Transplanted hPSC-Cardiomyocytes in the Infarcted Rat Heart.

Magnetic resonance in medicine·2026
Same author

Protocol for dual-optical mapping of voltage and calcium sensors in human pluripotent stem cell-derived cardiomyocytes.

STAR protocols·2025

Related Experiment Video

Updated: Feb 28, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.8K

Programming cells for cardiac repair.

Rocco Romagnuolo1, Michael A Laflamme2

  • 1Toronto General Research Institute, McEwen Centre for Regenerative Medicine, University Health Network, Toronto, ON, Canada.

Current Opinion in Biotechnology
|June 21, 2017
PubMed
Summary
This summary is machine-generated.

Researchers are exploring cell therapies to regenerate heart muscle after myocardial infarction (MI). Current adult stem cell trials show limited success, prompting investigation into reprogramming cells for improved heart repair and regeneration.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.3K
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.2K

Related Experiment Videos

Last Updated: Feb 28, 2026

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.8K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.3K
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.2K

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Biology
  • Stem Cell Therapy

Background:

  • The heart has limited regenerative capacity, leading to significant functional loss after myocardial infarction (MI).
  • Current clinical trials for MI primarily use adult stem cells, often from bone marrow, with generally disappointing outcomes.
  • The limited cardiogenic potential of adult stem cells may explain their suboptimal efficacy in restoring cardiac function.

Purpose of the Study:

  • To review strategies for reprogramming exogenous and endogenous cells into a cardiogenic state.
  • To summarize research on cell-based approaches aimed at achieving true heart regeneration after MI.
  • To evaluate the potential of these approaches to 'remuscularize' infarct scars with new, functional myocardium.

Main Methods:

  • Review of existing literature on cell programming and transplantation for cardiac repair.
  • Analysis of studies investigating the cardiogenic potential of various cell types.
  • Evaluation of preclinical and clinical data on cell-based therapies for myocardial infarction.

Main Results:

  • Adult stem cell therapies have shown limited success in restoring cardiac function post-MI.
  • Reprogramming strategies aim to enhance the cardiogenic potential of cells for improved heart regeneration.
  • The goal is to replace damaged cardiomyocytes and integrate new myocardium into the existing heart structure.

Conclusions:

  • Novel cell-based approaches, particularly those involving cell reprogramming, hold promise for treating heart failure after MI.
  • Overcoming the limitations of adult stem cells requires exploring more potent cardiogenic cell sources or reprogramming methods.
  • Effective heart regeneration necessitates the development of cell therapies that can effectively 'remuscularize' the injured heart.